Planning Your Regulatory Pathway Around Your Product Roadmap

Interview with Virtual Incision CEO John Murphy

John Murphy is a hands-on kind of operator. One of his favorite things about his company Virtual Incision is that it makes a physical product. Specifically, a brand new type of surgical robotic that is uniquely portable.

It’s named MIRA, an acronym for miniaturized in vivo robotic assistant. The first iteration is designed to perform colon resections, where part of the colon is removed and the two remaining ends reconnected. Virtual Incision already has plans to build more variations, which will be able to perform cholecystectomies (gallbladder removal), hysterectomies (uterus removal), and herniorrhaphies (hernia repairs).

These aren’t the first robots that can perform surgery. But so far, all the others are so big and expensive that only hospitals in metropolitan areas or those attached to universities are able to access them. In contrast, Virtual Incision’s robots are lightweight — approximately 2 lbs — and can be set up within 10 minutes. Target clients include community and rural hospitals, and ambulatory surgery centers.

John had an enviable resume even before he got involved with surgical robotics. With a degree in computer science, he worked in aerospace and life sciences, before getting an MBA and becoming CEO of a couple of private equity firms. He’s also part of Tri-Valley Ventures, a venture capital firm supporting startups on the eastern side of the San Francisco Bay.

In this episode of Medsider, John outlines his best advice on fundraising, regulatory approvals, and the dual-track approach to exiting.

Premium Members Only

Premium Members Only

You don't have access to this post, but if you become a premium member, you'll be able to see the whole thing, including many other exclusive benefits.

You don't have access to this post, but if you become a premium member, you'll be able to see the whole thing, including many other exclusive benefits.

You May Like These Articles

Medsider Premium

Become a premium member and unlock access to exclusive Medsider benefits.

Medsider Mentors

Medsider Mentors

Medsider Playbooks

Medsider Playbooks

Playbook

A Guide to Widespread Adoption in Medtech

In medtech, developing novel, impactful technology is often just the starting line. The real race begins when you try to integrate your solution into the often-resistant healthcare system – a hurdle that has tripped up countless promising companies. Here are the key strategies and lessons from five veterans in the medtech space on how to overcome this hurdle.

Copyright © Medsider 2024 • All rights reserved.

Subscribe

Sign In

Suggest a Guest

Copyright © Medsider 2024 • All rights reserved.

Subscribe

Sign In

Suggest a Guest

Copyright © Medsider 2024 • All rights reserved.

Subscribe

Sign In

Suggest a Guest